Longevity, philosophy and the small cap edge with Tobias Bucks from Ausbil Investment Management
Ausbil Investment Management's Tobias Bucks brings charm, original thinking and an unusual lens to global small cap investing, with a fascination for what longevity means across retirement, healthcare and markets. In this episode, Bucks talks about the opportunities arising from ageing populations, including hospice care and skilled nursing, and how AI is compressing timelines in drug development. He explains his process for finding niche leaders with high gross margins and positive earnings revisions in the $1 billion to $15 billion range, a space where the market is inefficient enough for active managers to make a real difference.
